Profile: IPCA Laboratories Ltd (IPCA.BO)

IPCA.BO on Bombay Stock Exchange

676.55INR
31 Jul 2015
Change (% chg)

Rs-17.55 (-2.53%)
Prev Close
Rs694.10
Open
Rs690.00
Day's High
Rs694.00
Day's Low
Rs675.00
Volume
17,949
Avg. Vol
28,781
52-wk High
Rs829.20
52-wk Low
Rs591.25

Search Stocks
Ipca Laboratories Ltd. is an India-based pharmaceutical company. The Company's formulations business in India consists of 13 marketing divisions focusing on therapeutic segments, including non-steroidal anti-inflammatory drugs (NSAID), cardiovascular and anti-diabetics, anti-malarial, anti-bacterial, gastro intestinal (GI) products, cough preparations, dermatology, neuro psychiatry, urology, neutraceutical and others. The Company manufactures over 350 formulations and 80 active pharmaceutical ingredients (API). The Company also offers Disease Modifying Anti-Rheumatic Drugs treatment for rheumatoid arthritis. The Company exports its APIs to the United States, Canada, Brazil, Mexico and generic formulations to the United States, Canada and branded formulations to Panama, West Indies, Venezuela, Peru and Colombia in this sub-continent.

Company Address

IPCA Laboratories Ltd

142 AB, Kandivli Industrial Esta
Kandivli (West)
MUMBAI     400067
P: +9122.66474747
F: +9122.28686954

Company Web Links

Search Stocks